Skip to content

What Reddit Users Ask and Report About Oral and Sublingual Ketamine

Michael Alvear

preprint DOI: 10.2139/ssrn.6765281 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Qualitative study
Population Reddit users discussing oral and sublingual ketamine therapy in a self-selected online community
Intervention sublingual ketamine
Duration Six-month review
Topics Esketamine Ketamine
Key findings The review identifies recurring patient-reported themes in Reddit discussions of oral and sublingual ketamine therapy, including dosing uncertainty, gastrointestinal side effects, bladder and urinary concerns, provider responsiveness, pharmacy variability, cost concerns, treatment tolerance, and integration support. The authors caution that these findings are not prevalence estimates and are best understood as a signal-detection and patient-experience analysis from a self-selected online community.

Abstract

This white paper analyzes aggregate coding results from a six-month review of Reddit discussions concerning oral and sublingual ketamine therapy. The analysis identifies recurring patient-reported themes, including dosing uncertainty, gastrointestinal side effects, bladder and urinary concerns, provider responsiveness, pharmacy variability, cost concerns, treatment tolerance, and integration support. Because the underlying source material concerns health-related Reddit discussions, the public dataset excludes usernames, post URLs, direct quotations, raw Reddit text, post-level records, and coder notes from individual posts. The findings should not be interpreted as prevalence estimates for all oral or sublingual ketamine patients. They are best understood as a signal-detection and patient-experience analysis from a self-selected online community.

Comparable studies

Other qualitative studies on ketamine, most cited first.

Study Year Design Participants
Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency? 2017 Qualitative review
Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study. Patients with treatment-resistant depression participating in off-label oral esketamine... 2022 Qualitative study n = 17
A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression Healthcare providers 2022 Quality improvement evaluation with mixed methods n = 94
Predictors of Psychedelic Experience: A Thematic Analysis First-person reports of psychedelic use from the Erowid database (six reports each for... 2022 Thematic analysis n = 22
Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychopathological Psychotic Experiences and Psychotic Disorders Experts in psychiatry, clinical psychology, medicine, and psychedelic effects 2024 Qualitative study n = 12

Explore topics